sch 39370 has been researched along with icatibant in 2 studies
| Studies (sch 39370) | Trials (sch 39370) | Recent Studies (post-2010) (sch 39370) | Studies (icatibant) | Trials (icatibant) | Recent Studies (post-2010) (icatibant) |
|---|---|---|---|---|---|
| 25 | 1 | 0 | 1,137 | 49 | 259 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, RG; Lew, RA; Madden, AC; Smith, AI; Tomoda, F | 1 |
| Chappell, MC; Ferrario, CM; Iyer, SN | 1 |
2 other study(ies) available for sch 39370 and icatibant
| Article | Year |
|---|---|
Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Consciousness; Dipeptides; Enzyme Inhibitors; Heart Rate; Kidney; Metalloendopeptidases; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Receptors, Bradykinin | 1996 |
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1998 |